The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2023 | Barriers to national lung cancer screening programmes
Lung cancer is a major health problem. Computerized tomography (CT) lung screening can reduce lung cancer mortality through early diagnosis. In this interview, Jens Vogel-Claussen, MD, Hannover Medical School, Hannover, Germany, shares challenges associated with the implementation of national lung cancer screening programmes. This interview took place at the 2023 World Conference on Lung Cancer (WCLC) in Singapore, Singapore.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
